• Home
  • RasGRP1 is a potential biomarker to stratify anti-EGFR therapy response in colorectal cancer.

RasGRP1 is a potential biomarker to stratify anti-EGFR therapy response in colorectal cancer.

Author List
Gbenedio OM, Bonnans C, Grun D, Wang CY, Hatch AJ, Mahoney MR, Barras D, Matli M, Miao Y, Garcia KC, Tejpar S, Delorenzi M, Venook AP, Nixon AB, Warren RS, Roose JP, Depeille P
Publication
JCI insight
Publication ID (Profile URL)
https://researcherprofiles.org/profile/57843532
Publication Year
2019
PubMed ID
31237864
Publication Title
Gbenedio OM, Bonnans C, Grun D, Wang CY, Hatch AJ, Mahoney MR, Barras D, Matli M, Miao Y, Garcia KC, Tejpar S, Delorenzi M, Venook AP, Nixon AB, Warren RS, Roose JP, Depeille P. RasGRP1 is a potential biomarker to stratify anti-EGFR therapy response in colorectal cancer. JCI Insight. 2019 06 25; 5.